文献速递淋巴瘤

整合基因组与转录组分析揭示与滤泡性淋巴瘤早期进展相关的基因改变

Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
PubMed 文献 · Br J Haematol · 2023-07-16

该研究分析415例滤泡性淋巴瘤(FL)患者的临床生物学特征,以识别与一线治疗后24个月内疾病进展(POD24)相关的变量。HIST1H1D驱动突变与POD24相关,6p22.2(HIST1H1D)和18q21.33(BCL2)获得及1p36.13(NBPF1)缺失可独立于FLIPI预测POD24。POD24队列基因表达显著富集炎症反应、细胞周期调控及PI3K-AKT-mTOR信号通路。

要点

  • FLIPI是logistic回归中预测POD24的最重要因素。
  • HIST1H1D驱动突变与POD24相关。
  • 6p22.2和18q21.33获得及1p36.13缺失可独立于FLIPI预测POD24。

核心结论

  • 在大规模FL患者队列中,研究强调了与疾病诊断和早期进展相关的独特基因改变和基因表达的重要性。

研究设计与样本

  • 研究分析了415例滤泡性淋巴瘤患者的临床生物学特征,以识别与一线治疗后24个月内疾病进展(POD24)相关的变量。

主要发现

  • 有B症状、乳酸脱氢酶和β2微球蛋白水平升高、基线血红蛋白水平不良、晚期疾病和高危FL国际预后指数(FLIPI)评分的患者POD24风险增加,其中FLIPI是logistic回归中最重要的因素。
  • HIST1H1D被鉴定为驱动突变,与POD24相关。
  • 6p22.2(HIST1H1D)和18q21.33(BCL2)获得及1p36.13(NBPF1)缺失可独立于FLIPI预测POD24。
  • FL样本基因表达谱显示,POD24队列显著富集炎症反应(由干扰素和肿瘤坏死因子介导)、细胞周期调控(转录、复制和增殖)基因集及PI3K-AKT-mTOR信号。
  • 该结果通过单细胞分辨率RNA-seq提供的全转录组信息进一步验证。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Follicular lymphoma (FL), the most common indolent lymphoma, is a clinically and genetically heterogeneous disease. However, the prognostic value of driver gene mutations and copy number alterations has not been systematically assessed. Here, we analysed the clinical-biological features of 415 FL patients to identify variables associated with disease progression within 24 months of first-line therapy (POD24). Patients with B symptoms, elevated lactate dehydrogenase and β2-microglobulin levels, unfavourable baseline haemoglobin levels, advanced stage, and high-risk FL International Prognostic Index (FLIPI) scores had an increased risk of POD24, with FLIPI being the most important factor in logistic regression. HIST1H1D, identified as a driver mutation, was correlated with POD24. Gains of 6p22.2 (HIST1H1D) and 18q21.33 (BCL2) and loss of 1p36.13 (NBPF1) predicted POD24 independent of FLIPI. Gene expression profiling of FL samples showed that the POD24 cohort was significantly enriched in the inflammatory response (mediated by interferon and tumour necrosis factor), cell cycle regulation (transcription, replication and proliferation) sets and PI3K-AKT-mTOR signalling. This result was further validated with transcriptome-wide information provided by RNA-seq at single-cell resolution. Our study, performed on a large cohort of FL patients, highlights the importance of distinctive genetic alterations and gene expression relevant to disease diagnosis and early progression.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Gao F, Liu H, Meng X, et al. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma. Br J Haematol. 2023. PMID: 37455019. doi:10.1111/bjh.18974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。